Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth Raetz, MD
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Children'S Hospital at Westmead
Sydney, New South Wales, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Hospital Sainte-Justine
Montreal, Quebec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S Hospital
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- David Geffen School of Medicine at Ucla
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Childrens Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- University of California San Francisco Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Saint Joseph Children'S Hospital of Tampa
Tampa, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- University of Kentucky
Lexington, Kentucky, United States
- Tulane University Health Sciences Center
New Orleans, Louisiana, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Wayne State University
Detroit, Michigan, United States
- University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- the Childrens Mercy Hospital
Kansas City, Missouri, United States
- Umdnj - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Columbia University Medical Center
New York, New York, United States
- New York University Langone Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2005
- Primary completion
- 30 Apr 2011
- Completion
- 30 Apr 2011
- Last update posted
- 12 Dec 2017
- Registered enrollment
- 134
- Registry id
- NCT00098839
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.